PROCEPT BioRobotics Corporation (PRCT) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
PROCEPT BioRobotics Corporation (PRCT) Bundle
Gain insights into your PROCEPT BioRobotics Corporation (PRCT) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with real PRCT data, enabling you to adjust forecasts and assumptions for a precise calculation of PROCEPT BioRobotics Corporation's intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.2 | 7.7 | 34.5 | 75.0 | 136.2 | 240.6 | 425.0 | 750.9 | 1,326.5 | 2,343.5 |
| Revenue Growth, % | 0 | 25.09 | 346.72 | 117.6 | 81.55 | 76.66 | 76.66 | 76.66 | 76.66 | 76.66 |
| EBITDA | -39.8 | -45.1 | -51.1 | -77.7 | -98.1 | -227.1 | -401.3 | -708.9 | -1,252.3 | -2,212.4 |
| EBITDA, % | -644.46 | -583.84 | -148.13 | -103.52 | -72.03 | -94.41 | -94.41 | -94.41 | -94.41 | -94.41 |
| Depreciation | 1.5 | 2.7 | 3.0 | 4.3 | 3.8 | 36.8 | 65.0 | 114.8 | 202.8 | 358.3 |
| Depreciation, % | 24.22 | 35.03 | 8.64 | 5.76 | 2.8 | 15.29 | 15.29 | 15.29 | 15.29 | 15.29 |
| EBIT | -41.3 | -47.8 | -54.0 | -82.0 | -101.9 | -228.5 | -403.6 | -713.1 | -1,259.7 | -2,225.5 |
| EBIT, % | -668.68 | -618.87 | -156.77 | -109.27 | -74.82 | -94.96 | -94.96 | -94.96 | -94.96 | -94.96 |
| Total Cash | 42.0 | 100.1 | 304.3 | 221.9 | 257.2 | 240.6 | 425.0 | 750.9 | 1,326.5 | 2,343.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.1 | 1.5 | 4.5 | 15.3 | 48.4 | 51.4 | 90.7 | 160.3 | 283.1 | 500.2 |
| Account Receivables, % | 17.81 | 20.07 | 12.95 | 20.36 | 35.52 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 |
| Inventories | 6.7 | 7.5 | 13.1 | 28.5 | 39.8 | 145.5 | 257.0 | 453.9 | 801.9 | 1,416.7 |
| Inventories, % | 108.38 | 96.89 | 38.14 | 38.05 | 29.19 | 60.45 | 60.45 | 60.45 | 60.45 | 60.45 |
| Accounts Payable | 1.4 | 1.2 | 2.0 | 9.4 | 13.5 | 32.6 | 57.6 | 101.8 | 179.9 | 317.7 |
| Accounts Payable, % | 23.41 | 16.07 | 5.89 | 12.52 | 9.91 | 13.56 | 13.56 | 13.56 | 13.56 | 13.56 |
| Capital Expenditure | -7.6 | -.2 | -.6 | -2.7 | -25.2 | -61.0 | -107.8 | -190.4 | -336.4 | -594.2 |
| Capital Expenditure, % | -123.37 | -3.02 | -1.72 | -3.54 | -18.51 | -25.36 | -25.36 | -25.36 | -25.36 | -25.36 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -41.9 | -52.5 | -56.3 | -88.0 | -101.9 | -228.5 | -403.6 | -713.1 | -1,259.7 | -2,225.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -54.4 | -51.4 | -61.7 | -105.2 | -163.5 | -342.3 | -572.3 | -1,011.0 | -1,786.1 | -3,155.4 |
| WACC, % | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4,873.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3,218 | |||||||||
| Terminal Value | -45,264 | |||||||||
| Present Terminal Value | -29,270 | |||||||||
| Enterprise Value | -34,143 | |||||||||
| Net Debt | -178 | |||||||||
| Equity Value | -33,965 | |||||||||
| Diluted Shares Outstanding, MM | 47 | |||||||||
| Equity Value Per Share | -718.76 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: PROCEPT BioRobotics Corporation’s (PRCT) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Innovative Surgical Technologies: State-of-the-art robotic systems designed for minimally invasive procedures.
- Comprehensive Clinical Data: Access to extensive research and clinical studies supporting product efficacy.
- Customizable Treatment Plans: Tailor solutions to meet individual patient needs and conditions.
- Real-Time Surgical Insights: Advanced analytics for monitoring and improving surgical outcomes.
- User-Friendly Interface: Intuitive design for seamless integration into surgical workflows.
How It Works
- Step 1: Download the prebuilt Excel template with PROCEPT BioRobotics Corporation’s (PRCT) data included.
- Step 2: Explore the pre-filled sheets and understand the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including PROCEPT BioRobotics Corporation’s (PRCT) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for PROCEPT BioRobotics Corporation (PRCT)?
- User-Friendly Interface: Crafted for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Valuation: Observe immediate updates to PROCEPT’s valuation as you tweak the inputs.
- Preloaded Data: Comes with PROCEPT’s actual financial metrics for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling PROCEPT BioRobotics Corporation (PRCT) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for PROCEPT BioRobotics Corporation (PRCT).
- Consultants: Deliver professional valuation insights on PROCEPT BioRobotics Corporation (PRCT) to clients quickly and accurately.
- Business Owners: Understand how innovative companies like PROCEPT BioRobotics Corporation (PRCT) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios involving PROCEPT BioRobotics Corporation (PRCT).
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for PROCEPT BioRobotics Corporation (PRCT).
- Real-World Data: PROCEPT BioRobotics Corporation's historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company’s performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for stakeholders.